Canada markets open in 1 hour 52 minutes

Protagonist Therapeutics, Inc. (PGF.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
15.200.00 (0.00%)
As of 08:29PM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 726.44M
Enterprise Value 425.53M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)26.91
Price/Book (mrq)2.35
Enterprise Value/Revenue 12.09
Enterprise Value/EBITDA -3.32

Trading Information

Stock Price History

Beta (5Y Monthly) 2.05
52-Week Change 3-11.63%
S&P500 52-Week Change 323.57%
52 Week High 342.80
52 Week Low 310.80
50-Day Moving Average 331.01
200-Day Moving Average 330.82

Share Statistics

Avg Vol (3 month) 3179
Avg Vol (10 day) 3180
Shares Outstanding 547.55M
Implied Shares Outstanding 6N/A
Float 840.77M
% Held by Insiders 11.69%
% Held by Institutions 199.96%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -131.59%
Operating Margin (ttm)38.41%

Management Effectiveness

Return on Assets (ttm)-19.32%
Return on Equity (ttm)-28.59%

Income Statement

Revenue (ttm)60M
Revenue Per Share (ttm)1.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -92.67M
Net Income Avi to Common (ttm)-78.95M
Diluted EPS (ttm)-2.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)341.62M
Total Cash Per Share (mrq)5.86
Total Debt (mrq)1.14M
Total Debt/Equity (mrq)0.34%
Current Ratio (mrq)16.71
Book Value Per Share (mrq)5.83

Cash Flow Statement

Operating Cash Flow (ttm)-70.24M
Levered Free Cash Flow (ttm)-43.31M